Laboratory research materials for in vitro use only.

$20 flat-rate shipping across Canada  ·  Free shipping on orders over $350

Klow Blend (BPC-157 + TB-500 + GHK-Cu + KPV)

For laboratory research use only (in vitro). Not for human or animal use.

$218.97

65 in stock

15% OFF Create an account and get 15% off your first order

Volume Pricing

QuantityDiscountUnit Price
1-2 unitsStandard$218.97Your price
3-4 units5% off$208.02Your price
5-9 units10% off$197.07Your price
10+ units Best Value15% off$186.12Your price

25% Pre-Order Discount Applied

The 25% pre-order discount is the maximum available and overrides volume pricing. There is no additional volume discount.

Pay via Interac e-Transfer

Why researchers choose PBC:

  • HPLC-verified purity on every lot
  • Certificate of Analysis included
  • Temperature-controlled shipping
  • Canadian lab — documented supply chain
  • Batch-level traceability

Accepted payment methods:

Interac e-Transfer

Certificate of Analysis available upon request. Contact us for lot-specific documentation.

Product Specifications

Format Lyophilized Powder
Net Quantity 80mg
Vials Per Kit 10

For laboratory research use only (in vitro). Not for human or animal use.

Description

Chemical Identity

Klow Blend is a proprietary multi-peptide research formulation containing four well-characterized research compounds: BPC-157 (Body Protection Compound-157), TB-500 (Thymosin Beta-4 fragment), GHK-Cu (Copper Tripeptide), and KPV (Lys-Pro-Val tripeptide). Each component has an independent body of published research, and the Klow Blend formulation provides researchers with a co-lyophilized preparation for investigating potential combinatorial effects across tissue repair, anti-inflammatory, and wound healing pathways.

Klow Blend is a proprietary designation unique to Prescott Bio Canada.

Component Description
BPC-157 15-amino acid pentadecapeptide; investigated for tissue repair via VEGFR2 signaling
TB-500 Thymosin Beta-4 active fragment; studied for actin regulation and tissue remodeling
GHK-Cu Copper-binding tripeptide; researched for wound healing and collagen synthesis
KPV Anti-inflammatory tripeptide derived from alpha-MSH; investigated for NF-kB modulation

Research Overview

The Klow Blend combines four peptides that have been individually investigated across complementary research domains. The formulation is designed for researchers studying multi-target approaches to tissue repair, inflammation modulation, and wound healing in preclinical models.

Key areas of published research for individual components include:

  • BPC-157 (Tissue Repair Research): BPC-157 has been extensively investigated in preclinical models of gastrointestinal, musculoskeletal, and vascular injury. Published research demonstrates activation of the VEGFR2-Akt-eNOS signaling axis, promoting angiogenesis and tissue repair in rodent models of tendon damage, muscle injury, and gastrointestinal lesions. BPC-157 remains entirely preclinical with no completed human clinical trials.
  • TB-500 (Tissue Remodeling): TB-500, the active fragment of Thymosin Beta-4, has been studied for its role in actin sequestration, cell migration, and tissue remodeling. Preclinical research has demonstrated effects on wound healing, cardiac repair following ischemic injury, and reduction of inflammation in various tissue models.
  • GHK-Cu (Copper Peptide Biology): GHK-Cu is a naturally occurring copper-binding tripeptide that has been investigated for stimulation of collagen synthesis, glycosaminoglycan production, and wound healing. Research has demonstrated antioxidant activity, matrix metalloproteinase modulation, and promotion of tissue regeneration in skin and connective tissue models.
  • KPV (Anti-Inflammatory Peptide): KPV (Lys-Pro-Val) is a tripeptide derived from the C-terminal region of alpha-melanocyte stimulating hormone (alpha-MSH). Research has demonstrated anti-inflammatory effects through inhibition of NF-kB nuclear translocation and suppression of pro-inflammatory cytokine production in immune cell and colitis models.

While each component has an independent research base, the specific combination in Klow Blend has not been evaluated in published studies. Researchers should evaluate individual component literature to inform experimental design and hypothesis generation.

Specifications

All Klow Blend supplied by Prescott Bio Canada is manufactured to research-grade standards.

Specification Detail
Purity Research grade (individual components >98% HPLC)
Form Lyophilized powder (co-lyophilized)
Appearance White to off-white powder
Storage (lyophilized) -20°C, protected from light
Storage (reconstituted) 2-8°C, use within 30 days
Solubility Soluble in bacteriostatic water, sterile water, or normal saline

Each vial is accompanied by a Certificate of Analysis (COA) documenting quality control testing results for individual components.

Research Applications

Klow Blend is supplied exclusively for in vitro and in vivo laboratory research. Potential experimental applications include:

  • Investigation of multi-peptide approaches to tissue repair and wound healing in preclinical models
  • Study of combinatorial anti-inflammatory effects across NF-kB, VEGFR2, and melanocortin signaling pathways
  • Examination of potential synergistic or additive effects between tissue-repair peptides in injury models
  • Research into co-formulation stability and compatibility of multi-peptide lyophilized preparations

Researchers should consult the primary literature for each individual component and institutional review protocols before designing experiments with Klow Blend.

Storage and Handling

Lyophilized powder: Store at -20°C in the original sealed vial, protected from light and moisture. Under these conditions, Klow Blend maintains stability for up to 24 months.

Reconstituted solution: Reconstitute with bacteriostatic water or sterile water to the desired concentration. Store reconstituted Klow Blend at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles.

Handling precautions: This product is intended for research use only (RUO). Not for human or veterinary diagnostic or therapeutic use. Handle using standard laboratory safety practices including appropriate PPE.

Additional information

Size

80mg

Published Research

3 references

References are provided for informational purposes to support in vitro laboratory research. No claims are made regarding therapeutic applications.

Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in human tendon fibroblasts

Chang CH, Tsai WC, Lin MS, et al. (2014). Molecules. PubMed 25415472

Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon anastomosis and counteracts cuprizone brain injuries and motor disability

Sikiric P, Seiwerth S, Rucman R, et al. (2013). Journal of Physiology and Pharmacology. PubMed 24304574

Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after amputation in rats treated with heparin, warfarin or aspirin

Stupnisek M, Franjic S, Drmic D, et al. (2015). Blood Coagulation & Fibrinolysis. PubMed 25897838

For laboratory research use only (in vitro). Not for human or animal use.

Research Use Certification

This website supplies laboratory reference materials intended solely for in vitro research purposes. By entering, you confirm: